Search Results - "Borroni, E"

The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 by Liguori, M., Digifico, E., Vacchini, A., Avigni, R., Colombo, F. S., Borroni, E. M., Farina, F. M., Milanesi, S., Castagna, A., Mannarino, L., Craparotta, I., Marchini, S., Erba, E., Panini, N., Tamborini, M., Rimoldi, V., Allavena, P., Belgiovine, C.

“…In cancer, myeloid cells have tumor-supporting roles. We reported that the protein GPNMB (glycoprotein nonmetastatic B) was profoundly upregulated in…”
Get full text

Impact of air pollution exposure on the severity of major depressive disorder: Results from the DeprAir study by Borroni, E, Buoli, M, Nosari, G, Ceresa, A, Fedrizzi, L, Antonangeli, L M, Monti, P, Bollati, V, Pesatori, A C, Carugno, M

“…Major depressive disorder (MDD) is one of the most prevalent medical conditions worldwide. Different factors were found to play a role in its etiology,…”
Get full text

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy by Aapro, M., Rugo, H., Rossi, G., Rizzi, G., Borroni, M.E., Bondarenko, I., Sarosiek, T., Oprean, C., Cardona-Huerta, S., Lorusso, V., Karthaus, M., Schwartzberg, L., Grunberg, S.

“…Antiemetic guidelines recommend co-administration of agents that target multiple molecular pathways involved in emesis to maximize prevention and control of…”
Get full text

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy by Gralla, R.J., Bosnjak, S.M., Hontsa, A., Balser, C., Rizzi, G., Rossi, G., Borroni, M.E., Jordan, K.

“…Safe, effective and convenient antiemetic regimens that preserve benefit over repeated cycles are needed for optimal supportive care during cancer treatment…”
Get full text

Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease? by Migliori, G. B., Centis, R., D'Ambrosio, L., Spanevello, A., Borroni, E., Cirillo, D. M., Sotgiu, G.

Get full text

Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study by Riccardi, N., Saderi, L., Borroni, E., Tagliani, E., Cirillo, D. M., Marchese, V., Matteelli, A., Piana, A., Castellotti, P., Ferrarese, M., Gualano, G., Palmieri, F., Girardi, E., Codecasa, L., Sotgiu, G.

“…BACKGROUND: Treatment outcomes in multidrug-resistant TB (MDR-TB) patients are suboptimal in several low-incidence countries.METHODS: The primary outcome…”
Get full text

Decreasing trend of drug-resistant TB in Italy by Giannoni, F., Lanni, A., Iacobino, A., Cirillo, D. M., Borroni, E., Fattorini, L., the Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA)

“…BACKGROUND: TB caused by rifampicin-resistant (RR) and multidrug-resistant (MDR) Mycobacterium tuberculosis strains is a major concern to TB control globally…”
Get full text

What are you sexting? Parental practices, sexting attitudes and behaviors among Italian adolescents by Confalonieri, E, Cuccì, G, Olivari, M. G, Parise, M, Borroni, E, Villani, D

“…Abstract Background Sexting has recently emerged as a public health and social issue. The present study had two aims: a) to preliminarily test adolescent…”
Get full text

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies by Schwartzberg, Lee, Karthaus, Meinolf, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria E., Rugo, Hope S., Jordan, Karin, Hansen, Vincent

“…Aim To assess the efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) over multiple chemotherapy cycles. Methods Two randomized phase III studies…”
Get full text

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX 2 receptor by Malherbe, P, Borroni, E, Gobbi, L, Knust, H, Nettekoven, M, Pinard, E, Roche, O, Rogers‐Evans, M, Wettstein, JG, Moreau, J‐L

“…Background and purpose:  The OX 2 receptor is a G‐protein‐coupled receptor that is abundantly found in the tuberomammillary nucleus, an important site for the…”
Get full text

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX2 receptor by Malherbe, P, Borroni, E, Gobbi, L, Knust, H, Nettekoven, M, Pinard, E, Roche, O, Rogers‐Evans, M, Wettstein, JG, Moreau, J‐L

“…Background and purpose:  The OX2 receptor is a G‐protein‐coupled receptor that is abundantly found in the tuberomammillary nucleus, an important site for the…”
Get full text

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice by Steiner, M A, Wanisch, K, Monory, K, Marsicano, G, Borroni, E, Bächli, H, Holsboer, F, Lutz, B, Wotjak, C T

“…Dysregulation of the endocannabinoid system is known to interfere with emotional processing of stressful events. Here, we studied the role of cannabinoid…”
Get full text

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders by Saenger, S, Goeldner, C, Frey, J.R, Ozmen, L, Ostrowitzki, S, Spooren, W, Ballard, T.M, Prinssen, E, Borroni, E, Metzger, F

“…Abstract Objective Due to its potent neurotrophic activity, insulin-like growth factor I (IGF-I) has been proposed many times for therapeutic application in…”
Get full text

Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey by Samo Gudo, P, Cuna, Z, Coelho, E, Maungate, S, Borroni, E, Miotto, P, Ahmadova, S, Brouwer, M, Migliori, G B, Zignol, M, Cirillo, D M

Get full text

Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides by Bourson, A, Borroni, E, Austin, R H, Monsma, Jr, F J, Sleight, A J

“…The purpose of the present study was to determine possible physiological functions of the 5-ht6 receptor using antisense oligonucleotides (AOs) in male rats…”
Get more information

P.1.c.040 Partial occupancy of the glycine transporter type 1 by RG1678 leads to efficacy in animal models relevant to schizophrenia by Alberati, D, Borroni, E, Moreau, J.L, Wong, D, Wallace, T, Hainzl, D, Pinard, E, Wettstein, J.G

Get full text

The chemoattractant decoy receptor D6 as a negative regulator of inflammatory responses by Borroni, E M, Buracchi, C, de la Torre, Y Martinez, Galliera, E, Vecchi, A, Bonecchi, R, Mantovani, A, Locati, M

“…Other than signalling receptors sustaining leucocyte recruitment during inflammatory reactions, the chemokine system includes 'silent' receptors with distinct…”
Get more information

Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis by Vetrano, S, Correale, C, Borroni, E M, Pagano, N, Savino, B, Locati, M, Malesci, A, Repici, A, Danese, S

“…Immune reactivity towards the bacterial intestinal flora plays an important part in the pathogenesis of inflammatory bowel disease. Administration of probiotic…”
Get more information

OC1.08.1 THE ATYPICAL CHEMOKINE RECEPTOR D6 CONTROLS INTESTINAL INFLAMMATION AND INFLAMMATION-ASSOCIATED COLON CANCER by Vetrano, S, Correale, C, Borroni, E, Bonecchi, R, Arena, V, Fantini, M, Malesci, A, Vecchi, A, Mantovani, A, Locati, M, Danese, S

Get full text

OC3.03.4 UNIQUE ROLE OF JUNCTIONAL ADHESION MOLECULE-A IN MAINTAINING MUCOSAL HOMEOSTASIS IN INFLAMMATORY BOWEL DISEASE by Vetrano, S, Rescigno, M, Cera, M.R, Doni, A, Correale, C, Fantini, M, Sturm, A, Borroni, E, Repici, A, Rumi, C, Locati, M, Malesci, A, Dejana, E, Danese, S

Get full text